4
Clinical Trials associated with Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)A Randomized, Blind, Controlled Clinical Trial to Evaluate Safety and Immunogenicity of Live Attenuated Varicella Vaccine After a Two-dose Vaccination Course in Healthy Population Aged ≥13 Years Old
This is a randomized, blind, controlled clinical trial of live attenuated varicella vaccines manufactured by Shanghai Institute of Biological Products Co.,Ltd. The purpose of this study is to evaluate the immunogenicity and safety of a two doses vaccination of investigational vaccine with 0,28 day and 0,56 day immunization schedule in population aged ≥13 years old.
/ CompletedNot ApplicableIIT Clinical study on VARICELLA VACCINE LIVE ATTENUATED BIKEN in subjects aged 50 years or older with underlying disease which influences on the immune system
Start Date03 Nov 2016 |
Sponsor / Collaborator- |
/ Active, not recruitingPhase 3 随机、盲法、同类疫苗对照试验评价水痘减毒活疫苗在13岁及13岁以上健康人群中接种二剂疫苗的免疫原性和安全性
[Translation] A randomized, blinded, controlled trial of similar vaccines to evaluate the immunogenicity and safety of two doses of live attenuated varicella vaccine in healthy people aged 13 years and above
评价水痘减毒活疫苗在13岁及13岁以上健康人群中以6周的间隔接种二剂的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of live attenuated varicella vaccine given as two doses at 6-week intervals in healthy people aged 13 years and older.
100 Clinical Results associated with Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
100 Translational Medicine associated with Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
100 Patents (Medical) associated with Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
100 Deals associated with Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)